No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleonly females |
313377 |
2. Check conditionsNone |
313377 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
133 |
4. Check minimum number of eventsNone |
133 |
5. Include endpointsNone |
133 |
6. Filter based on genotype QC (FinnGen only) |
124 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of vagina, including Hilmo
based on the number of shared cases.
Similar with more cases:
- malignant neoplasm of female genital organs, including Hilmo
- Solid cancers, including Hilmo
- Malignant neoplasm, wide definition
- Malignant neoplasm, including Hilmo
- Neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 124 | 124 | - |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | - |
| Median age at first event (years) | 65.77 | 65.77 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 128
- Matched controls
- 1280
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
89.7
96.9
53
10
A04AA01
ATC
ondansetron; systemic, rectal
44.3
71.8
46
16
128
Kela drug reimbursment
Cancers of female genital organs
+∞
64.0
56
*
C52.91
ICD-10 Finland
Squamous cell carcinoma of the vagina
+∞
62.8
55
*
LEB00
NOMESCO Finland
Biopsy of vagina
139.9
55.5
56
7
XX3DW
NOMESCO Finland
Time consuming IT work
24.5
52.9
42
25
A03FA01
ATC
metoclopramide; systemic, rectal
13.3
50.7
79
138
8070/3-C52.9
ICD-O-3
Squamous cell carcinoma, NOS, of vagina, NOS
+∞
45.6
41
*
ULA02
NOMESCO Finland
Kolposcopy
12.7
43.7
56
74
WF002
NOMESCO Finland
Radical radiotherapy
198.7
41.5
41
*
C52.90
ICD-10 Finland
Malignant neoplasm of vagina without histologic examination
+∞
40.8
37
*
JN4AD
NOMESCO Finland
Body CT examination
15.7
40.0
40
36
JN4BD
NOMESCO Finland
Extensive body CT
18.2
37.1
33
24
C52
ICD-10 Finland
Malignant neoplasm of vagina
+∞
31.6
29
*
Z51.5
ICD-10 Finland
Palliative care
14.4
31.5
32
29
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
28.2
26
*
C52.99
ICD-10 Finland
Malignant tumor of the vagina, unspecified histology
+∞
28.2
26
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
7.9
28.1
52
102
L03AA13
ATC
pegfilgrastim; parenteral
+∞
27.0
25
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
27.0
25
*
WZC00
NOMESCO Finland
Treatment plan or consultation
6.9
26.6
80
250
N02AA05
ATC
oxycodone; systemic
6.8
25.3
57
135
A04AA02
ATC
granisetron; systemic, transdermal
+∞
24.8
23
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
23.7
22
*
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
146.3
23.5
24
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
277.7
23.4
23
*
C52.92
ICD-10 Finland
Adenocarcinoma of the vagina
+∞
22.6
21
*
B01AB10
ATC
tinzaparin; parenteral
7.2
20.2
36
66
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
65.7
19.6
22
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
6.5
19.0
38
78
A04AD12
ATC
aprepitant; systemic
+∞
18.1
17
*
130
Kela drug reimbursment
Malignant tumour
+∞
18.1
17
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
18.1
17
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
18.1
17
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
17.0
16
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
4.6
16.6
77
314
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
+∞
16.0
15
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
15.2
15.7
26
21
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
15.2
15.2
25
20
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
20.1
14.9
22
13
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
14.9
14
*
L02BG04
ATC
letrozole; oral
34.5
14.3
18
6
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
84.0
13.9
15
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
13.8
13
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
13.8
13
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
13.8
13
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
13.8
13
*
ZZR00
NOMESCO Finland
Flap of skin
155.8
13.7
14
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
25.8
13.3
18
8
UKC02
NOMESCO Finland
Cystoscopy
5.0
13.2
34
86
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.1
12.8
25
49
115
Kela drug reimbursment
Breast cancer
+∞
12.7
12
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
12.7
12
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
12.7
12
*
YX9VG
NOMESCO Finland
Other MRI eamination with high intensity magnet for dose design of radiotherapy
+∞
12.7
12
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
12.7
12
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
12.7
12
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
12.7
12
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
42.0
12.5
15
*
WW500
NOMESCO Finland
Blood transfusion
25.8
11.9
16
7
ZX090
NOMESCO Finland
Other technic of radiotherapy
71.7
11.8
13
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
17.2
11.7
18
12
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
11.6
11
*
LEC00
NOMESCO Finland
Partial excision of vagina
+∞
11.6
11
*
X77
ICPC
Malignant neopl genital female other
+∞
11.6
11
*
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
5.7
11.2
23
47
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
119.4
10.6
11
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
119.4
10.6
11
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
119.4
10.6
11
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
10.6
10
*
L03AA02
ATC
filgrastim; parenteral
+∞
10.6
10
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
10.6
10
*
YL1CD
NOMESCO Finland
Very extensive CT examination of pelvis for dose design of radiotherapy
+∞
10.6
10
*
A79
ICPC
Malignancy NOS
+∞
10.6
10
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
10.6
10
*
LEB10
NOMESCO Finland
Excision of lesion of vagina
32.8
9.6
12
*
D39.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other female genital organs
107.7
9.5
10
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
9.5
9
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
9.5
9
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.5
9
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.4
9.5
27
73
WZC30
NOMESCO Finland
Teaching
4.1
9.1
29
85
N93.9
ICD-10 Finland
Abnormal uterine and vaginal bleeding, unspecified
17.9
8.8
13
8
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
8.4
8
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
8.4
8
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
8.4
8
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
9.4
8.1
16
19
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
16.4
7.9
12
8
LFC00
NOMESCO Finland
Partial excision of vulva
84.8
7.5
8
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
84.8
7.5
8
*
ZX120
NOMESCO Finland
Intravenous
7.4
7.4
17
26
JN4CD
NOMESCO Finland
Very extensive body CT
17.0
7.4
11
7
D07.1
ICD-10 Finland
Carcinoma in situ: Vulva
+∞
7.4
7
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
7.4
7
*
8077/2-C52.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vagina, NOS
+∞
7.4
7
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
7.4
7
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
7.4
7
*
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
3.9
7.3
24
72
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
7.1
25
78
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
6.6
6.9
17
29
J01EA01
ATC
trimethoprim; systemic
2.6
6.6
63
346
HA1AA
NOMESCO Finland
X-ray mammography
5.8
6.6
18
35
B01AB05
ATC
enoxaparin; parenteral
2.6
6.6
56
291
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
8.9
6.5
13
16
TJF80
NOMESCO Finland
Ostomy education
73.4
6.5
7
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
6.3
76
464
A06AH03
ATC
naloxegol; oral
28.2
6.3
8
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
6.3
6
*
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
+∞
6.3
6
*
C53.00
ICD-10 Finland
Malignant tumor of endocervix without histology
+∞
6.3
6
*
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
+∞
6.3
6
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
6.3
6
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
6.3
6
*
C51.81
ICD-10 Finland
Squamous cell carcinoma of the vulva
+∞
6.3
6
*
C529, 8085, 3
ICD-O-3
+∞
6.3
6
*
8140/3-C52.9
ICD-O-3
Adenocarcinoma, NOS, of vagina, NOS
+∞
6.3
6
*
TKC20
NOMESCO Finland
Catheterisation of bladder
4.3
6.2
17
44
TPH07
NOMESCO Finland
Cathetrisation of artery
3.6
6.2
22
69
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.9
6.1
13
18
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
35
63
7.27
19.94
3.7
1.3
3.77
2.77
ug/l
0.47
26
49
54
164
4.97
17.22
7.1
1.9
0.75
0.82
mmol/l
4.35
54
149
87
495
3.37
9.59
4.4
2.3
—
—
estimate
—
0
0
97
591
3.65
9.52
21.1
6.1
3.97
4.17
e9/l
0.32
91
508
76
404
3.17
9.34
5.1
3.1
—
—
—
0
0
54
242
3.13
8.84
2.2
1.4
—
—
—
0
0
18
44
4.60
7.08
1.7
1.5
—
—
—
0
0
58
320
2.49
5.89
4.1
3.0
0.40
0.56
e6/l
0.52
46
225
34
144
2.85
5.87
10.1
4.4
102.47
104.45
mmol/l
1.26
34
144
24
83
3.33
5.84
1.8
1.6
50.00
62.86
ml/min/173m2
—
8
28
38
173
2.70
5.71
2.6
1.8
—
—
—
0
0
72
444
2.42
5.65
4.8
1.9
2.38
2.37
mmol/l
0.10
67
390
5
0
+∞
5.24
1.4
0.0
19.78
—
u/ml
—
5
0
30
127
2.78
5.14
2.7
1.8
—
—
—
0
0
46
241
2.42
5.10
4.2
1.8
—
—
—
0
0
20
72
3.11
4.53
13.3
3.3
7.57
8.71
mmol/l
0.49
20
67
30
137
2.55
4.39
2.6
1.8
—
—
—
0
0
20
76
2.93
4.13
2.4
1.5
—
—
—
0
0
31
152
2.37
3.88
14.3
7.1
—
—
—
0
0
13
35
4.01
3.72
3.1
1.3
2.57
1.19
ug/l
0.32
13
29
10
22
4.84
3.51
1.9
1.4
—
—
—
0
0
58
378
1.98
3.47
8.1
4.0
0.00
0.00
estimate
-0.00
15
120
7
10
7.33
3.41
1.7
1.3
—
—
—
0
0
6
7
8.91
3.30
2.5
1.4
—
—
—
0
0
12
36
3.57
3.11
1.3
1.2
—
—
—
0
0
84
635
1.94
3.11
9.8
5.2
1.21
1.23
mmol/l
1.33
75
559
9
21
4.53
3.06
1.4
1.2
—
—
—
0
0
10
27
3.93
2.95
1.7
1.7
91.10
97.11
%
—
10
27
6
9
6.93
2.90
1.7
1.3
—
—
—
0
0
36
212
1.97
2.79
4.3
2.7
1.19
1.45
e6/l
0.20
19
103
5
6
8.60
2.77
1.4
1.0
—
—
—
0
0
5
6
8.60
2.77
1.4
1.0
—
—
—
0
0
5
6
8.60
2.77
1.6
1.2
—
—
—
0
0
5
6
8.60
2.77
1.4
1.0
—
—
—
0
0
9
24
3.95
2.73
1.8
1.2
—
—
—
0
0
89
702
1.88
2.71
7.5
4.2
0.00
0.01
estimate
0.50
17
127
87
685
1.84
2.63
7.4
4.1
0.00
0.00
estimate
-0.00
14
129
5
7
7.37
2.57
1.6
1.1
—
—
—
0
0
16
73
2.36
2.32
6.6
2.2
0.53
0.61
%
0.69
16
73
8
23
3.64
2.31
2.6
1.5
—
—
—
0
0
46
310
1.76
2.29
6.3
4.1
1.02
1.02
kg/l
0.09
38
216
16
74
2.33
2.26
6.6
2.2
1.05
1.23
%
0.58
16
74
14
62
2.41
2.16
1.8
1.6
—
—
—
0
0
86
696
1.72
2.14
7.5
4.1
0.00
0.00
estimate
-0.00
17
134
38
539
0.58
2.07
1.8
1.9
1.83
1.29
mmol/l
1.45
31
461
5
11
4.68
1.96
1.4
1.1
—
—
—
0
0
5
11
4.68
1.96
1.4
1.1
—
—
—
0
0
5
11
4.68
1.96
1.4
1.1
—
—
—
0
0
106
1153
0.53
1.78
5.9
6.6
2.77
2.71
mmol/l
0.27
100
1055
101
1113
0.56
1.77
6.7
7.0
40.01
39.60
mmol/mol
0.17
92
1041
6
18
3.44
1.77
1.3
1.0
—
—
—
0
0
5
13
3.95
1.73
1.2
1.7
—
—
—
0
0
8
31
2.68
1.69
1.6
2.1
—
—
—
0
0
6
19
3.26
1.68
1.7
1.5
—
—
—
0
0
6
19
3.26
1.68
1.3
1.1
—
—
—
0
0
6
19
3.26
1.68
1.7
1.5
—
—
—
0
0
14
70
2.12
1.66
6.4
5.8
93.82
94.40
%
0.14
14
70
30
196
1.69
1.62
4.3
3.0
1.24
4.15
e6/l
2.04
13
88
12
57
2.22
1.61
2.1
1.4
—
—
—
0
0
21
124
1.83
1.59
3.0
1.8
382.24
376.54
nmol/l
0.03
21
112
8
33
2.52
1.56
1.3
1.1
—
—
—
0
0
14
72
2.06
1.56
6.4
5.6
1.42
1.31
%
0.18
14
72
18
102
1.89
1.54
3.2
3.5
—
—
—
0
0
97
1072
0.61
1.52
4.7
4.6
1.45
1.26
mmol/l
2.14
92
965
43
313
1.56
1.51
2.5
2.3
2.86
3.14
mg/l
0.43
37
263
5
16
3.21
1.45
1.2
1.2
—
—
—
0
0
6
24
2.57
1.32
1.3
1.0
—
—
—
0
0
107
1148
0.59
1.30
5.9
5.6
6.02
5.96
mmol/l
0.28
99
1047
13
70
1.95
1.29
5.7
5.7
0.70
0.64
%
0.22
13
70
36
262
1.52
1.25
1.6
1.7
1.68
1.20
mg/l
0.58
28
206
60
489
1.43
1.17
4.6
4.1
68.15
89.76
ng/l
0.10
48
356
61
507
1.39
1.03
8.4
3.9
0.00
0.02
estimate
0.50
12
99
90
989
0.70
1.02
6.4
4.9
15.36
14.98
pmol/l
0.67
85
908
20
136
1.56
0.93
12.2
2.6
1.01
1.03
mmol/l
0.08
20
112
17
245
0.65
0.88
1.3
1.3
3.05
10.04
u/ml
—
8
88
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
5
24
2.13
0.75
2.0
3.0
0.14
0.55
iu/ml
—
5
15
11
68
1.68
0.74
11.4
4.7
26.25
25.61
mmol/l
0.33
11
68
15
101
1.55
0.74
2.2
4.0
395.20
226.92
ng/l
0.29
15
91
20
267
0.70
0.70
1.3
1.3
21.87
37.70
iu/ml
—
7
92
117
1114
1.58
0.70
31.0
13.8
28.11
20.05
mg/l
1.99
111
871
117
1210
0.62
0.67
52.0
21.7
37.47
39.57
%
5.92
117
1188
117
1210
0.62
0.67
52.5
21.7
123.09
131.91
g/l
8.48
117
1186
117
1209
0.62
0.64
51.7
21.5
92.15
91.21
fl
1.10
117
1187
0
20
0.00
0.61
0.0
1.1
—
—
—
0
0
6
35
1.75
0.58
2.5
1.7
—
—
—
0
0
14
192
0.70
0.57
1.0
1.6
—
—
—
0
0
60
531
1.24
0.56
4.2
2.9
177.05
86.89
ug/l
2.00
54
490
47
408
1.24
0.51
1.7
1.7
24.77
21.57
nmol/l
0.45
41
339
8
59
1.38
0.42
1.5
1.5
—
—
—
0
0
5
33
1.54
0.42
2.8
1.6
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
85.40
—
0
5
0
15
0.00
0.41
0.0
1.3
—
3.57
—
0
7
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
518.90
—
0
10
0
18
0.00
0.40
0.0
1.1
—
61.49
—
0
10
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
117
1195
0.76
0.29
40.1
18.7
81.01
70.70
umol/l
0.93
117
1170
87
910
0.86
0.28
41.1
17.5
14.30
13.64
%
3.17
87
900
8
66
1.23
0.27
1.5
1.6
—
—
—
0
0
43
469
0.87
0.25
3.3
3.7
7.23
5.28
mg/mmol
0.30
26
261
44
404
1.14
0.24
3.0
3.1
1800.16
1295.35
ng/l
0.26
38
343
27
303
0.86
0.23
1.2
1.3
0.80
2.23
u/ml
0.92
12
68
5
38
1.33
0.23
1.2
1.8
—
—
—
0
0
5
39
1.29
0.23
3.8
2.5
43.80
43.09
u/l
—
5
34
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
72.71
—
0
13
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
86
890
0.90
0.18
4.0
4.8
16.91
12.81
mm/h
1.65
80
819
5
68
0.72
0.17
1.6
1.3
—
—
—
0
0
63
601
1.10
0.16
3.1
2.6
68.99
81.79
nmol/l
3.76
57
535
59
614
0.93
0.12
2.2
2.2
90.83
103.97
pmol/l
1.62
35
275
116
1174
0.87
0.10
36.1
17.4
3.99
3.96
mmol/l
0.54
116
1139
5
43
1.17
0.10
1.4
1.4
—
—
—
0
0
5
45
1.12
0.10
1.4
1.2
—
—
—
0
0
5
45
1.12
0.10
1.4
1.2
—
—
—
0
0
116
1173
0.88
0.09
36.1
17.3
138.84
139.92
mmol/l
3.69
116
1142
7
68
1.03
0.08
1.3
1.0
—
—
—
0
0
63
614
1.05
0.07
2.9
2.7
—
—
—
0
0
12
110
1.10
0.05
1.5
1.5
—
—
—
0
0
36
358
1.01
0.00
7.7
3.7
0.00
0.00
estimate
-0.00
12
104
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
14.60
—
0
5
0
5
0.00
0.00
0.0
1.6
—
8.24
—
0
5
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
4.43
—
0
5
0
5
0.00
0.00
0.0
1.6
—
10.04
—
0
5
0
5
0.00
0.00
0.0
1.8
—
218.00
—
0
5
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
64.58
—
0
8
0
6
0.00
-0.00
0.0
1.0
—
10.82
—
0
6
0
8
0.00
-0.00
0.0
1.1
—
4.05
—
0
8
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_VAGINA_WIDE – Malignant neoplasm of vagina, including Hilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).